Home Tags Merck

Tag: Merck

Merck To Buy Blood Cancer Biotech Imago For $1.35B

Merck has agreed to acquire Imago BioSciences, a California-based biotechnology company focused on bone marrow disorders, for more than $1 billion in cash. The deal announced Monday...

Spain’s Competition Regulator Fines Merck

Spain's competition watchdog has slapped a 39 million-euro ($38.45 million) fine on US-based Merck for anti-competitive behaviour in a case brought by Spanish rival Insud...
Merck

Merck Eyes $28B Purchase Of Seagen

Merck & Co. already owns a stake in antibody-drug conjugate specialist Seagen. But now, the New Jersey pharma appears to want the whole thing. The...
Merck

Germany & Austria Approve Merck’s Acquisition Of Acceleron

Merck has received antitrust clearance from the competition authorities in Germany and Austria to tender an offer for the acquisition of clinical-stage biopharmaceutical firm...
Merck

Merck Delays $11.5B Acceleron Deal, Giving DOJ & FTC More Review...

Merck’s $11.5 billion Acceleron Pharma buyout may not happen quite as soon as the Kenilworth, NJ-based pharma company had hoped, reported Fierce Pharma. Merck revealed...
Merck

Merck To Buy Acceleron For $11.5B

Merck is buying Acceleron Pharma Ifor about US$11.5 billion, broadening its portfolio beyond aging cancer drug Keytruda with potential treatments that could bring in...
Merck

Merck, Pfizer’s Wyeth Settle Vaccine Patent Case

Merck Sharp & Dohme Corp and Pfizer's Wyeth subsidiary have resolved a patent dispute over their competing vaccines for preventing diseases including pneumonia and...
Merck

Merck’s Vaccine Antitrust Cases Can Proceed As Class Action

A lawsuit accusing Merck of illegally stifling competition for its rotavirus vaccine RotaTeq can proceed as a class action, a Philadelphia federal judge has...

Germany: Merck to buy Versum for US$6.56B

Merck announced Friday, April 12, it has signed a definitive agreement to acquire Versum Materials in a deal with an enterprise value of US$6.6...

Germany: Merck presses Versum sherholders to back its $4.5B bid

According the Financial Times, Merck has ramped up its efforts to torpedo the US$4.5 billion takeover of US chemicals group Versum Materials by Entegris,...
Enable Notifications    OK No thanks